HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study.

Abstract
The disposition of intramuscular artemether (AM) was studied in 26 Kenyan children with cerebral malaria. Antimalarial activity determined by bioassay was compared with total plasma AM plus dihydroartemisinin (DHA) determined by high power liquid chromatography (HPLC). Therapeutic levels were achieved in most subjects (21/26) within 1 h of receiving intramuscular AM (3.2 mg/kg), with close correlation between bioassay and HPLC measurements (r = 0.706). However, there was marked inter-individual variation, antimalarial activity was undetectable in 5 subjects ('non-absorbers'), and plasma concentrations were lower in subject with respiratory distress. The 50% parasite clearance time was significantly longer in non-absorbers (mean = 13.1 h, SD = 10.8 vs. mean = 7.8 h, SD = 5.5; P = 0.013). We conclude that the bioavailability of intramuscular AM in children with severe malaria may be highly variable, particularly in the presence of respiratory distress, and may be associated with an inadequate therapeutic response.
AuthorsS A Murphy, E Mberu, D Muhia, M English, J Crawley, C Waruiru, B Lowe, C R Newton, P Winstanley, K Marsh, W M Watkins
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene (Trans R Soc Trop Med Hyg) 1997 May-Jun Vol. 91 Issue 3 Pg. 331-4 ISSN: 0035-9203 [Print] England
PMID9231211 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimalarials
  • Artemisinins
  • Sesquiterpenes
  • artenimol
  • Artemether
Topics
  • Antimalarials (administration & dosage, blood, pharmacokinetics)
  • Artemether
  • Artemisinins
  • Biological Availability
  • Child
  • Child, Preschool
  • Chromatography, High Pressure Liquid
  • Female
  • Humans
  • Infant
  • Injections, Intramuscular
  • Kenya
  • Malaria, Cerebral (blood, drug therapy)
  • Male
  • Respiratory Insufficiency (complications)
  • Sesquiterpenes (administration & dosage, blood, pharmacokinetics)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: